Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 80Years
All Genders
NCT07353671

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Led by West China Hospital · Updated on 2026-03-25

60

Participants Needed

2

Research Sites

69 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.

CONDITIONS

Official Title

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 80 years, any gender
  • Confirmed diagnosis of head and neck cancer, including nasopharyngeal carcinoma, requiring radical or postoperative radiotherapy
  • ECOG Performance Status score between 0 and 2
  • Voluntary agreement to participate and signed informed consent
Not Eligible

You will not qualify if you...

  • History of prior radiotherapy to the target treatment area
  • Presence of open wounds, infections, rash, psoriasis, or other skin conditions in the treatment area that affect assessment
  • Having connective tissue diseases or other systemic skin disorders
  • Known allergy to any component of Meilian Fuxin Solution
  • Participation in other interventional clinical trials within the past 3 months or use of investigational drugs/devices
  • Considered unsuitable for the study by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Sichuan University West China Hospital, Chengdu, Sichuan

Chengdu, Sichuan, China, 610041

Actively Recruiting

2

Sichuan University West China Hospital

Chengdu, Sichuan, China

Actively Recruiting

Loading map...

Research Team

X

Xingchen Peng

CONTACT

R

Ruiwan Yuan

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis | DecenTrialz